TSX:PPTA
TSX:PPTAMetals and Mining

Assessing Perpetua Resources (TSX:PPTA) Valuation After Strong Recent Share Price Momentum

What recent performance in Perpetua Resources (TSX:PPTA) is signaling to investors Perpetua Resources (TSX:PPTA) has caught investor attention after a 22.8% move over the past week, adding to gains over the past month and past 3 months, and leaving its 1 year total return above 100%. See our latest analysis for Perpetua Resources. The recent 22.8% 7 day share price return, alongside a 21.2% year to date share price return and very large 3 year total shareholder return, points to momentum...
NYSE:AZO
NYSE:AZOSpecialty Retail

Is It Time To Reassess AutoZone (AZO) After Its Recent Flat Share Performance

If you are wondering whether AutoZone's share price really reflects what the business is worth today, this breakdown is designed to help you put a clear number on that question. After a long term return of 165.5% over 5 years and 40.2% over 3 years, the stock has been quieter lately, with a 0.3% return over the last year and short term moves of a 2.3% decline over 7 days and a 5.2% decline over 30 days. Recent coverage of AutoZone has focused on how the stock's long term performance compares...
NYSE:CNA
NYSE:CNAInsurance

Is CNA Financial (CNA) Share Price Reflecting Its Earnings And Book Value Profile Today

If you are wondering whether CNA Financial's current share price reflects its true worth, you are in the right place because this article is all about what the numbers might be saying about value. CNA Financial's recent share price of US$47.01 comes with a mixed return profile, with a 1.5% decline over the last 7 days but gains of 5.2% over 30 days, 7.2% over 1 year, 36.7% over 3 years, and 67.9% over 5 years. These moves have played out alongside ongoing interest in the broader insurance...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

A Look At Innoviz Technologies (INVZ) Valuation After InnovizThree LiDAR And NVIDIA Edge Processing Reveal

Innoviz Technologies (INVZ) has drawn fresh attention after unveiling InnovizThree, a long range colored LiDAR with integrated RGB camera, alongside an edge processing tie up with NVIDIA Jetson Orin Nano, which was showcased at CES 2026. See our latest analysis for Innoviz Technologies. The recent CES 2026 product unveilings and partnerships have arrived after a mixed stretch for the stock, with a 7 day share price return of 33.63% and a 90 day share price return decline of 45.45%, while the...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Assessing PDF Solutions (PDFS) Valuation After Fresh Analyst Interest In Semiconductor Analytics

Recent analyst coverage of PDF Solutions (PDFS) has drawn fresh attention to the stock as investors weigh the company’s role in semiconductor manufacturing analytics and its focus on process optimization and yield management across advanced production environments. See our latest analysis for PDF Solutions. The recent analyst attention comes after a choppy few weeks for PDF Solutions, with a 1-day share price return of a 5.12% decline, a 7-day share price return of 6.59%, and a 90-day share...
NYSE:GSL
NYSE:GSLShipping

A Look At Global Ship Lease (GSL) Valuation As Trade Disruptions Support Containership Demand

Recent geopolitical disruptions, changing tariffs, and rerouted trade flows are putting fresh attention on containership operators, with Global Ship Lease (GSL) positioned around rising demand for capacity that supports more complex and diversified supply chains. See our latest analysis for Global Ship Lease. Against this backdrop, Global Ship Lease’s share price at US$35.98 comes after a 31.27% 90 day share price return. Its 1 year total shareholder return of 73.28% points to momentum that...
SEHK:9966
SEHK:9966Biotechs

Is Alphamab Oncology (SEHK:9966) Quietly Reframing Its Immuno-Oncology Edge With JSKN033’s Phase II IND?

In late 2025, Alphamab Oncology’s board announced that China’s Center for Drug Evaluation had accepted its Investigational New Drug application for a phase II trial of JSKN033, a high-concentration subcutaneous co-formulation combining a HER2-targeting bispecific ADC and a PD-L1 inhibitor with platinum-based chemotherapy, with or without bevacizumab, in advanced cervical cancer. This acceptance marks a key progression in Alphamab Oncology’s immuno-oncology pipeline, highlighting its effort...
TSE:6136
TSE:6136Machinery

OSG (TSE:6136) Net Margin Holds At 8.9% And Tests Bullish Growth Narratives

OSG (TSE:6136) has wrapped up FY 2025 with fourth quarter revenue of ¥44,625 million and basic EPS of ¥57.02, capping a year in which trailing twelve month revenue came in at ¥160,619 million and EPS at ¥172.10. Over the past few quarters, the company has seen revenue move from ¥40,191 million in Q4 FY 2024 to ¥44,625 million in Q4 FY 2025, while quarterly EPS shifted from ¥42.59 to ¥57.02 over the same period. This gives you a clear view of how the top line and EPS have tracked together...
NYSE:DLX
NYSE:DLXCommercial Services

How Deluxe’s Visa Direct-Powered dlxFastFunds Launch Could Reshape Cash-Flow Access for DLX Investors

On 8 January 2026, Deluxe announced a collaboration with Visa to integrate Visa Direct into its platform, launching dlxFastFunds to help businesses access funds in near real-time and bypass typical one- to two-day settlement delays. This move deepens Deluxe’s role in business cash-flow management by embedding faster funding options directly into the Deluxe Payments Platform, potentially enhancing its appeal to customers needing rapid access to capital for operations. Next, we’ll examine how...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

A Look At Pebblebrook Hotel Trust (PEB) Valuation After Barclays Underweight Call And Earnings Miss

Pebblebrook Hotel Trust (PEB) moved into focus after Barclays began coverage with an Underweight rating, alongside the company’s Hotel Montrose at Beverly Hills sale, third quarter 2025 earnings miss, and slightly higher than expected revenue. See our latest analysis for Pebblebrook Hotel Trust. Those headlines have hit around a period of improving momentum for Pebblebrook Hotel Trust, with a 90 day share price return of 16.96% and a year to date share price return of 3.29%, even as the 1...
TSE:3407
TSE:3407Chemicals

Assessing Asahi Kasei (TSE:3407) Valuation After Strong Multi Month Share Price Momentum

Asahi Kasei (TSE:3407) has drawn renewed attention after recent share price moves, with the stock showing a mix of short term volatility and stronger multi month returns that invite a closer look. See our latest analysis for Asahi Kasei. At a share price of ¥1,444, Asahi Kasei has seen a 90 day share price return of 21.86%, while the 1 year total shareholder return of 40.51% suggests momentum has been building over a longer stretch. If Asahi Kasei’s recent run has caught your eye, it could be...
OM:BETS B
OM:BETS BHospitality

A Look At Betsson (OM:BETS B) Valuation After New Senior Bond Listing On Nasdaq Stockholm

Why Betsson’s New Bond Listing Matters for Equity Investors Betsson (OM:BETS B) has published a prospectus and applied to list €75 million of senior unsecured bonds on Nasdaq Stockholm, an issuance tied to a €250 million framework to support its growth plans. See our latest analysis for Betsson. At a share price of SEK 137.2, Betsson has a 1 day share price return of 1.40%, a 30 day share price return decline of 4.85% and a 3 year total shareholder return of 87.76%. This points to momentum...
XTRA:TKMS
XTRA:TKMSAerospace & Defense

A Look At TKMS & Co KGaA’s Valuation As India Submarine Talks And Analyst Upgrade Draw Focus

TKMS & Co KGaA (XTRA:TKMS) is in focus after being added to the Germany MDAX Index, drawing fresh attention to its naval defense footprint, recent contract activity, and evolving earnings profile. See our latest analysis for TKMS & Co KGaA. The index inclusion and interest around new submarine contracts have arrived alongside a strong swing in the share price, with a 7 day share price return of 17.44% and a 30 day share price return of 10.81%. This points to building momentum rather than a...